Skip to content

Clinical trials

Phase 2 Weight Gain trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Phase 2 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20082
20101
20191
20201
20222
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics2
The University of Texas Health Science Center, Houston2
University of North Carolina, Chapel Hill2
Aardvark Therapeutics, Inc.1
Children's Hospital Medical Center, Cincinnati1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
National Institute of Allergy and Infectious Diseases (NIAID)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
University of Pittsburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain12
Obesity7
Mental Disorders2
Schizophrenia2
Bipolar Disorder1
Body-Weight Trajectory1
Bulimia1
Neonatal Abstinence Syndrome1
Overweight1
Pediatric Obesity1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.